Traditional CROs fragment device development with costly hand-offs and learning curves. Veranex unites the essential disciplines for medical device & diagnostic development under one roof from sketch to evidence-generation to market launch.
All connected. All aligned. All accelerating your path to market—delivering breakthrough devices and diagnostics that improve patient lives sooner.
Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.
Purpose-built solutions. Proven results. User & Patient-centered innovation.
Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity. Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.
We are the Innovation CRO.
Legacy of excellence. Proven execution. Patient impact accelerated.
With Veranex, your medical device development pathway is optimized to help you realize your innovation and growth objectives so you can deliver real advances in clinical care that make a difference for patients. Veranex and our legacy companies are certified throughout our business units.
Product Design & Engineering
Our Providence and Minneapolis locations are ISO 13485:2016 certified and compliant to 21 CFR part 820.
Veranex Inc., has implemented a strong quality management system and security posture based on the principles of the CIA (Confidentiality, Integrity and Availability) Triad for information security.
Our consulting and training services on regulatory affairs, quality management and clinical affairs for medical devices and in-vitro diagnostics manufacturers are ISO 9001 and ISO 13485 certified.
Successful audits performed by the FDA in 2013 at our Paris Facility, and 2018 at our Atlanta, GA facility.
Both preclinical facilities have strong expertise of preclinical studies prepared for FDA submissions, and our Paris facility is well versed in preparations for European Notified Body submissions.
All studies are performed according to basic “good practices” which imply high quality standards. Moreover, studies can be performed according to Good Laboratory Practice (21 CFR part 58).
Both Veranex Preclinical Services facilities in Paris and Atlanta are fully accredited by AAALAC International, demonstrating our commitment to the highest standards of animal care and use in research.
Main Certificates and Guidelines:
Agrement de la Prefecture
FDA
Compacts Regs™ Part 58
AAALAC International accredited program
Animal Care Policy:
Fully accredited by AAALAC International.
Preclinical research is at the level of practicing veterinary medicine: all studies and procedures are supervised by veterinarians (13 DVMs on staff).
A Senior Veterinarian fully dedicated to animal care.
Careful Ethics Committee oversight.
Need an expert opinion?
Contact one of our experts to accelerate your innovation today.
